SCHEMBL6431092

SCHEMBL6431092

O=C(NCc1cccs1)OC1=NOC2(CCN(C(=O)c3cccc4ccccc34)CC2)C1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.41
ALDH1A1 P00352 4/20 0.40
LMNA P02545 3/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CASP3 P42574 1/20 0.39
CTSK P43235 1/20 0.39
CTSF Q9UBX1 1/20 0.39
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
TGM2 P21980 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CCR5 P51681 1/20 0.37
MAPK1 P28482 1/20 0.35
METAP2 P50579 1/20 0.35
TACR1 P25103 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6411043 0.88 SMN1; SMN2 (0.41) ALDH1A1LMNAJAK2JAK1CTSL
SCHEMBL2401537 0.85 AVPR1A (0.43) AVPR1AALDH1A1LMNAJAK2JAK1
SCHEMBL6410177 0.85 POLB (0.38) ALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL6433711 0.84 AVPR1A (0.43) AVPR1AALDH1A1LMNAJAK2JAK1
SCHEMBL6415977 0.82 ABL1 (0.41) ALDH1A1LMNAPOLBHTTSMN1; SMN2
SCHEMBL6411592 0.82 POLB (0.41) ALDH1A1LMNAJAK2JAK1CTSL
SCHEMBL6410752 0.81 USP7 (0.39) ALDH1A1LMNAPOLBHTTSMN1; SMN2
SCHEMBL6415283 0.79 PKM (0.45) ALDH1A1LMNAPOLBSMN1; SMN2KDM4E
SCHEMBL6412136 0.79 SMN1; SMN2 (0.39) ALDH1A1LMNAPOLBSMN1; SMN2METAP2
SCHEMBL6409445 0.78 USP7 (0.36) ALDH1A1LMNASMN1; SMN2METAP2TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP claimed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP disclosed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP disclosed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO disclosed